Literature DB >> 23908469

TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses.

Heather B Cohen1, Katharine T Briggs, John P Marino, Katya Ravid, Simon C Robson, David M Mosser.   

Abstract

Sepsis is a highly fatal disease caused by an initial hyperinflammatory response followed by a state of profound immunosuppression. Although it is well appreciated that the initial production of proinflammatory cytokines by macrophages accompanies the onset of sepsis, it remains unclear what causes the transition to an immunosuppressive state. In this study, we reveal that macrophages themselves are key regulators of this transition and that the surface enzyme CD39 plays a critical role in self-limiting the activation process. We demonstrate that Toll-like receptor (TLR)-stimulated macrophages modulate their activation state by increasing the synthesis and secretion of adenosine triphosphate (ATP). This endogenous ATP is paradoxically immunosuppressive due to its rapid catabolism into adenosine by CD39. Macrophages lacking CD39 are unable to transition to a regulatory state and consequently continue to produce inflammatory cytokines. The importance of this transition is demonstrated in a mouse model of sepsis, where small numbers of CD39-deficient macrophages were sufficient to induce lethal endotoxic shock. Thus, these data implicate CD39 as a key "molecular switch" that allows macrophages to self-limit their activation state. We propose that therapeutics targeting the release and hydrolysis of ATP by macrophages may represent new ways to treat inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23908469      PMCID: PMC3772500          DOI: 10.1182/blood-2013-04-496216

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

2.  Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

3.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

Review 4.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  NTPDase1 governs P2X7-dependent functions in murine macrophages.

Authors:  Sébastien A Lévesque; Filip Kukulski; Keiichi Enjyoji; Simon C Robson; Jean Sévigny
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

Review 6.  Shaping of monocyte and macrophage function by adenosine receptors.

Authors:  György Haskó; Pál Pacher; Edwin A Deitch; E Sylvester Vizi
Journal:  Pharmacol Ther       Date:  2006-09-14       Impact factor: 12.310

7.  Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

Authors:  Konrad Wilhelm; Jayanthi Ganesan; Tobias Müller; Christoph Dürr; Melanie Grimm; Andreas Beilhack; Christine D Krempl; Stephan Sorichter; Ulrike V Gerlach; Eva Jüttner; Alf Zerweck; Frank Gärtner; Patrizia Pellegatti; Francesco Di Virgilio; Davide Ferrari; Neeraja Kambham; Paul Fisch; Jürgen Finke; Marco Idzko; Robert Zeiser
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

8.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

9.  A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.

Authors:  Bryan G Belikoff; Stephen Hatfield; Peter Georgiev; Akio Ohta; Dmitriy Lukashev; Jon A Buras; Daniel G Remick; Michail Sitkovsky
Journal:  J Immunol       Date:  2011-01-17       Impact factor: 5.422

10.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

View more
  64 in total

1.  IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response.

Authors:  Heather B Cohen; Amanda Ward; Kajal Hamidzadeh; Katya Ravid; David M Mosser
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

Review 2.  Extrinsic and intrinsic control of macrophage inflammatory responses.

Authors:  Heather B Cohen; David M Mosser
Journal:  J Leukoc Biol       Date:  2013-08-20       Impact factor: 4.962

Review 3.  Immunopathogenesis of abdominal sepsis.

Authors:  Georg F Weber; Filip K Swirski
Journal:  Langenbecks Arch Surg       Date:  2014-01       Impact factor: 3.445

4.  The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling.

Authors:  Bryan D Fleming; Prabha Chandrasekaran; Laura A L Dillon; Elizabeth Dalby; Rahul Suresh; Arup Sarkar; Najib M El-Sayed; David M Mosser
Journal:  J Leukoc Biol       Date:  2015-06-05       Impact factor: 4.962

5.  P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.

Authors:  Luiz Eduardo Baggio Savio; Mariana G Juste Andrade; Paola de Andrade Mello; Patrícia Teixeira Santana; Aline Cristina Abreu Moreira-Souza; Janaína Kolling; Aline Longoni; Linda Feldbrügge; Yan Wu; Angela T S Wyse; Simon C Robson; Robson Coutinho-Silva
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

6.  CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.

Authors:  Patrick S Murphy; Jing Wang; Samir P Bhagwat; Joshua C Munger; William J Janssen; Terry W Wright; Michael R Elliott
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

7.  The transition of M-CSF-derived human macrophages to a growth-promoting phenotype.

Authors:  Kajal Hamidzadeh; Ashton T Belew; Najib M El-Sayed; David M Mosser
Journal:  Blood Adv       Date:  2020-11-10

8.  CD39 improves survival in microbial sepsis by attenuating systemic inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Gábor Törő; Balázs Koscsó; Endre Kókai; Simon C Robson; Keiichi Enjyoji; Rolando H Rolandelli; Katalin Erdélyi; Pál Pacher; György Haskó
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

9.  Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.

Authors:  Nadia R Sutton; Takanori Hayasaki; Matthew C Hyman; Anuli C Anyanwu; Hui Liao; Danica Petrovic-Djergovic; Linda Badri; Amy E Baek; Natalie Walker; Keigo Fukase; Yogendra Kanthi; Scott H Visovatti; Ellen L Horste; Jessica J Ray; Sascha N Goonewardena; David J Pinsky
Journal:  JCI Insight       Date:  2017-01-12

10.  The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.

Authors:  Sènan M d'Almeida; Gilles Kauffenstein; Charlotte Roy; Laetitia Basset; Loukas Papargyris; Daniel Henrion; Véronique Catros; Norbert Ifrah; Philippe Descamps; Anne Croue; Pascale Jeannin; Marc Grégoire; Yves Delneste; Julie Tabiasco
Journal:  Oncoimmunology       Date:  2016-04-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.